We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AstraZeneca PLC and its Japanese partner Daiichi-Sankyo Co Ltd have withdrawn an application in the European Union fo ...
AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday announced they have been granted a breakthrough therapy designati ...
Women with incurable breast cancer in England and Wales will not be offered a life-extending drug on the national hea ...
AstraZeneca PLC on Monday said that its antibody drug conjugate Enhertu won another approval in China. The Cambridge ...
AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their cancer drug Enhertu received a priority review by the ...
AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow thi ...
d Daiichi Sankyo Co Ltd - Rahway, New Jersey-based and Tokyo-based pharmaceutical companies - Joint-developed monoclon ...
Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday reported "substantial clinical activity" for Enhertu in a recent ...
Daiichi Sankyo Co Ltd on Monday announced positive updates for Enhertu, with the cancer drug receiving support from U ...
AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their joint product Enhertu has received a third approval i ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions